1. Home
  2. ACXP vs SUGP Comparison

ACXP vs SUGP Comparison

Compare ACXP & SUGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • SUGP
  • Stock Information
  • Founded
  • ACXP 2017
  • SUGP 1998
  • Country
  • ACXP United States
  • SUGP Hong Kong
  • Employees
  • ACXP N/A
  • SUGP N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • SUGP
  • Sector
  • ACXP Health Care
  • SUGP
  • Exchange
  • ACXP Nasdaq
  • SUGP NYSE
  • Market Cap
  • ACXP 8.4M
  • SUGP 9.6M
  • IPO Year
  • ACXP 2021
  • SUGP 2024
  • Fundamental
  • Price
  • ACXP $0.47
  • SUGP $1.01
  • Analyst Decision
  • ACXP Strong Buy
  • SUGP
  • Analyst Count
  • ACXP 2
  • SUGP 0
  • Target Price
  • ACXP $10.00
  • SUGP N/A
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • SUGP 11.4M
  • Earning Date
  • ACXP 08-08-2025
  • SUGP 07-21-2025
  • Dividend Yield
  • ACXP N/A
  • SUGP N/A
  • EPS Growth
  • ACXP N/A
  • SUGP N/A
  • EPS
  • ACXP N/A
  • SUGP N/A
  • Revenue
  • ACXP N/A
  • SUGP $25,478,980.00
  • Revenue This Year
  • ACXP N/A
  • SUGP N/A
  • Revenue Next Year
  • ACXP N/A
  • SUGP N/A
  • P/E Ratio
  • ACXP N/A
  • SUGP N/A
  • Revenue Growth
  • ACXP N/A
  • SUGP 25.07
  • 52 Week Low
  • ACXP $0.30
  • SUGP $0.35
  • 52 Week High
  • ACXP $3.33
  • SUGP $3.25
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 52.38
  • SUGP 58.94
  • Support Level
  • ACXP $0.45
  • SUGP $0.43
  • Resistance Level
  • ACXP $0.59
  • SUGP $1.84
  • Average True Range (ATR)
  • ACXP 0.08
  • SUGP 0.16
  • MACD
  • ACXP -0.01
  • SUGP 0.10
  • Stochastic Oscillator
  • ACXP 27.06
  • SUGP 41.14

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About SUGP SU GROUP HLDGS LTD

SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment. Geographically operates in Hong Kong, and Other foreign countries, with maximum revenue from Kong Kong.

Share on Social Networks: